Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry
Our analysis shows that the incidence of MG is increasing in the Czech Republic and that patients with refractory disease, of whom up to 58% are female, have a higher burden of disease than non-refractory patients.
Authors
- Michala Jakubíková (ORCID: https://orcid.org/0000-0001-5554-4839)
- Magda Horáková (ORCID: https://orcid.org/0000-0003-3317-2661)
- Katarína Breciková
- Petr Hájek (ORCID: https://orcid.org/0000-0001-5579-1215)
- Stanislav Voháňka
- Aleš Tichopád (ORCID: https://orcid.org/0000-0002-1308-0877)
- Jana Junkerová
- Jiří Piťha
- Michaela Týblová (ORCID: https://orcid.org/0000-0002-9091-8629)
- Daniela Vlažná (ORCID: https://orcid.org/0000-0001-5241-1053)
- Jacek Cudny
Institutions
- Charles University (CZ)
- Masaryk University (CZ)
- University Hospital Ostrava (CZ)
- University Hospital Brno (CZ)
- Czech Technical University in Prague (CZ)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1007/s40120-024-00682-x
- Citations
- 2
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- UCB Pharma